Lynn A. Tetrault, Director at NEOGENOMICS INC (NEO), sold 12,224 shares at $15.97 ($195K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Scheduled sale ($195k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.97 | 6,112 | $98K | 50.0% |
| 2 | $15.97 | 6,112 | $98K | 50.0% |
| Total | $15.97 avg | 12,224 | $195K | 100% |
| Filing → |
| NEO | SELL | 2026-06-11 | $60K | — | Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-09-11 | $2.0M | — | Filing → |